Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Neutrophil Percentage-to-Albumin Ratio as a Predictor of Post-Induction Hemodynamic Vulnerability in Major Oncologic Surgery

NCT07804706 is registered in ClinicalTrials.gov with Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital as lead sponsor.

NCT NCT07804706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07804706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Neutrophil Percentage-to-Albumin Ratio as a Predictor of Post-Induction Hemodynamic Vulnerability in Major Oncologic Surgery
Lead sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2026
Completion date
December 15, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic instability, post-induction hypotension (pih)